Badly designed studies may lead to the efficacy of drugs being overestimated and money being wasted on trials that prove fruitless, according to a new study from McGill University in Canada.

Classified as: Research, animal research, mice, Clinical trials, drug trial, sunitinib, preclinical research, animal study, animal models, cancer drug, randomization, blinding, Jonathan Kimmelman, reproducibility, study design, guinea pig
Published on: 14 Oct 2015
Back to top